TRF significantly reduced serum TG, TC, and ApoA-1 levels but had no effect on LDL levels (Figure 4C), indicating that TRF lowers serum lipid levels, which may contribute to its protective effect against hepatic steatosis. The gene discussed is APOA1; the disease is Hepatic steatosis.